In recent years, the Shazam! actor has courted controversy in Hollywood for endorsing U.S. President Donald Trump in the 2024 presidential election and for his comments about the Covid-19 vaccine.

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most ...

In a major and controversial policy shift, the FDA announced in a New England Journal of Medicine article that updated ...

Low uptake may reflect barriers—misinformation, access or shifting insurance coverage—not simply waning need.

FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

The much-anticipated report calls for increased scrutiny of the vaccine schedule and describes the nation’s children as overmedicated.

On May 22, an FDA advisory committee unanimously recommended COVID-19 vaccine manufacturers target the JN.1 variant in their formulations.  The Vaccines and Related Biological Products Advisory ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

The vaccine is expected to remain available for anyone who is at least 65 or who has a medical condition, leaving many Americans ineligible. Here's what we know.

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.